Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa

International Journal of Antimicrobial Agents

Volumn 34, Issue 5, 2009, Pages 414-418

  Gorgani, Neda ^a,b   Ahlbrand, Scott ^a   Patterson, Andrew ^a   Pourmand, Nader ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAN JOSE STATE UNIVERSITY   (United States)

^c University of California Santa Cruz   (United States)

Author keywords

Antibiotic resistance; Pseudomonas aeruginosa; Pyrosequencing

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ASPARAGINE; ASPARTIC ACID; CIPROFLOXACIN; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GLUTAMIC ACID; ISOLEUCINE; LEVOFLOXACIN; PROTEIN MEXOZ; PROTEIN MEXR; PROTEIN MEXZ; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REGULATOR PROTEIN; THREONINE; TOBRAMYCIN; TYROSINE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; DNA SEQUENCE; GENE AMPLIFICATION; HOSPITAL PATIENT; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; SEQUENCE ANALYSIS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA GYRASE; DNA MUTATIONAL ANALYSIS; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; POINT MUTATION; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 69949120910     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.05.013     Document Type: Article

References (14)

1. Kollef M.H., and Micek S.T. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med 33 (2005) 1845-1853
2. Geissler A., Gerbeaux P., Granier I., Blanc P., Facon K., and Durand-Gasselin J. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med 29 (2003) 49-54
3. Nseir S., Di Pompeo C., Soubrier S., Delour P., Lenci H., Roussel-Delvallez M., et al. First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33 (2005) 283-289
4. Sherertz R.J., and Sarubbi F.A. A three-year study of nosocomial infections associated with Pseudomonas aeruginosa. J Clin Microbiol 18 (1983) 160-164
5. Lambert P.A. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med 95 Suppl. 41 (2002) 22-26
6. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 34 (2002) 634-640
7. Jalal S., Ciofu O., Høiby N., Gotoh N., and Wretlind B. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 44 3 (2000) 710-712 Erratum in
8. Aires J.R., Köhler T., Nikaido H., and Plésiat P. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 43 (1999) 2624-2628
9. Islam S., Jalal S., and Wretlind B. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 10 (2004) 877-883
10. Gharizadeh B., Herman Z.S., Eason R.G., Jejelowo O., and Pourmand N. Large-scale pyrosequencing of synthetic DNA: a comparison with results from Sanger dideoxy sequencing. Electrophoresis 27 (2006) 3042-3047
11. Gharizadeh B., Akhras M., Unemo M., Wretlind B., Nyrén P., and Pourmand N. Detection of gyrA mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by rapid and reliable pre-programmed short DNA sequencing. Int J Antimicrob Agents 26 (2005) 486-490
12. Nakano M., Deguchi T., Kawamura T., Yasuda M., Kimura M., Okano Y., et al. Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 41 (1997) 2289-2291
13. Yonezawa M., Takahata M., Matsubara N., Watanabe Y., and Narita H. DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 39 (1995) 1970-1972
14. Jalal S., and Wretlind B. Mechanisms of quinolone resistance in clinical stains of Pseudomonas aeruginosa. Microb Drug Resist 4 (1998) 257-261